Church of PeptidesSearch
Portrait of Plecanatide
New Disciples · approved 2017

Plecanatide

The Gentle Current

United States

Plecanatide is an oral analog of uroguanylin, a peptide involved in intestinal fluid regulation. By activating guanylate cyclase-C, it increases fluid secretion and supports bowel movement in adults with chronic idiopathic constipation or irritable bowel syndrome with constipation.

Evidence ladder: Approved human useApproved human use · product-specific labelsEducational record
ClassificationNew Disciples
Evidence summaryApproved human use · product-specific labels
OriginUnited States
Scientific record

What the evidence says

Established role or proposed benefit

  • Activates guanylate cyclase-C in the intestine.
  • Approved for defined chronic constipation disorders.

Side effects, risks, and limits

  • Diarrhea is the principal adverse effect.
  • Pediatric contraindications and age restrictions matter.
Doctide’s verdict

The Gentle Current is a character name, not a safety guarantee. Plecanatide has evidence for particular adult bowel disorders; its shared pathway with linaclotide does not make their pediatric labels or product instructions interchangeable.

Documented history

Where the real story begins

TRULANCE received initial US approval in 2017. Its clinical record includes separate placebo-controlled adult trial programs for chronic idiopathic constipation and irritable bowel syndrome with constipation. Those studies establish a defined bowel-disorder role, rather than a general digestive-health claim. Historical source.

United States · approved 2017
Book of the Canon · comic scripture

The laboratory legend

Plecanatide copied a message the intestine already understood and asked the river to move again. Doctide kept a mop nearby out of professional respect.

This bold passage is invented comedy, not scientific or historical fact.
Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 12, 2026
Evidence ledger

Sources

Source links checked: October 4, 2026. This authoritative medication reference describes particular medicinal formulations and uses; it is not evidence for every preparation or off-label claim.

  1. MedlinePlus: medication-specific uses and precautions
  2. FDA Drugs@FDA database
  3. TRULANCE prescribing information

Fiction disclosure: The bold laboratory legend is invented. The historical and scientific sections are factual summaries; no invented connective events were added.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.